Clinical Trial Update: A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of zolbetuximab (IMAB362) in adults with pancreatic cancer is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Zolbetuximab (zolbetuximab)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING